Physician profile
Mary E Bartz
NPI 1659321123
$5,310.17
in general payments reported to CMS, 2019-2025
41 companies · $727 in 2025
The $727 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $259 · 2021: $264 · 2022: $1,218 · 2023: $1,175 · 2024: $890 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,791.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $904.37 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Astrazeneca Pharmaceuticals Lp | $462.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $431.62 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $367.20 | 2019-2025 | Trintellix |
| Viiv Healthcare Company | $324.62 | 2019-2025 | Rukobia, Apretude |
| Lilly USA, LLC | $286.75 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.91 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $244.61 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $218.02 | 2020-2025 | |
| Emd Serono, INC. | $199.49 | 2019-2023 | Serostim |
| Abbott Laboratories | $169.65 | 2019-2024 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Janssen Biotech, INC. | $164.89 | 2019-2023 | Symtuza |
| Hologic Sales and Service, LLC | $128.12 | 2020-2025 | Aptima |
| Gilead Sciences, INC. | $112.04 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $111.13 | 2022-2025 | Pifeltro, Capvaxive, Gardasil 9 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Bartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.